We have previously shown using xenograft transplantation experiments that the NCAM+/ALDH1+ cell fraction from within the Wilms' tumor blastema is enriched for cancer stem cells (CSCs) (Pode-Shakked et al., 2013). This evidence concerns the gene ALDH1A1 and Wilms tumor.